Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms

被引:87
作者
Harger, JH
Adler, SP
Koch, WC
Harger, GF
机构
[1] Magee Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pediat, Richmond, VA 23298 USA
关键词
D O I
10.1016/S0029-7844(97)00701-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the risk of maternal parvovirus B19 infection from exposure to various sources and the fetal morbidity of those infections. Methods: We obtained demographic and occupational information about pregnant women exposed to sources of B19 and about the nature and duration of the exposures. We performed serologic testing 10-14 days after exposure using an indirect capture enzyme-linked immunosorbent assay. Women with immunoglobulin (Ig) M were examined with weekly ultrasound until 12 weeks after exposure, and the outcome of the pregnancy was ascertained from interviews with patients and their obstetricians. Logistic regression analysis was used to determine risk factors for maternal immunity and infection by B19. Results: Of 618 pregnant women exposed, 307 (49.7%) were immune to B19, 259 remained susceptible after exposure, and 52 (16.7% of all susceptibles) contracted B19 infection. None of the 52 fetuses of infected women developed:nonimmune hydrops, and there were no fetal deaths attributable to B19 in this group. The relative risk of maternal B19 infection was 2.8 if the source was a related child living in the household (95% confidence interval 1.7, 4.6; P < .001). No significant differences were found for maternal B19 infect:ion in eight categories of maternal occupation. Maternal symptoms of polyarthralgia (46%), fever (19%), and nonspecific rash (38%) were significantly more common (P < .001) in IgM-positive patients than in noninfected women (4.1%, 2.8%, and 5.7%, respectively). Only 17 (33%) of the IgM-positive women were entirely asymptomatic. Conclusion: The risk of maternal B19 infection in pregnancy could not be predicted by a gravida's occupation, but it was significantly higher when the source of exposure was her own child. The fetal risk of nonimmune hydrops after maternal B19 infection must be very low. As a consequence, exclusion of pregnant women from the workplace during endemic periods with seasonal clusters of cases is not justified. Weekly fetal ultrasound evaluation in these cases carries a low yield. (C) 1998 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 20 条
[1]   RISK OF HUMAN PARVOVIRUS B19 INFECTIONS AMONG SCHOOL AND HOSPITAL EMPLOYEES DURING ENDEMIC PERIODS [J].
ADLER, SP ;
MANGANELLO, AMA ;
KOCH, WC ;
HEMPFLING, SH ;
BEST, AM .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :361-368
[2]   HUMAN PARVOVIRUS INFECTION IN PREGNANCY AND HYDROPS-FETALIS [J].
ANAND, A ;
GRAY, ES ;
BROWN, T ;
CLEWLEY, JP ;
COHEN, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (04) :183-186
[3]   DETECTION OF ANTIBODIES AND ANTIGENS OF HUMAN PARVOVIRUS B19 BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ANDERSON, LJ ;
TSOU, C ;
PARKER, RA ;
CHORBA, TL ;
WULFF, H ;
TATTERSALL, P ;
MORTIMER, PP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :522-526
[4]  
BROWN T, 1984, LANCET, V2, P1033
[5]   OCCUPATIONAL RISK-FACTORS FOR INFECTION WITH PARVOVIRUS B19 AMONG PREGNANT-WOMEN [J].
CARTTER, ML ;
FARLEY, TA ;
ROSENGREN, S ;
QUINN, DL ;
GILLESPIE, SM ;
GARY, GW ;
HADLER, JL .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :282-285
[6]  
*CDC, 1988, MMWR-MORBID MORTAL W, V38, P81
[7]   THE PREVALENCE OF ANTIBODY TO HUMAN PARVOVIRUS-B19 IN ENGLAND AND WALES [J].
COHEN, BJ ;
BUCKLEY, MM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1988, 25 (02) :151-153
[8]   DIAGNOSTIC ASSAYS WITH MONOCLONAL-ANTIBODIES FOR THE HUMAN-SERUM PARVOVIRUS-LIKE VIRUS (SPLV) [J].
COHEN, BJ ;
MORTIMER, PP ;
PEREIRA, MS .
JOURNAL OF HYGIENE, 1983, 91 (01) :113-&
[9]   PARVOVIRUS B19 INFECTION IN-HOSPITAL WORKERS - COMMUNITY OR HOSPITAL ACQUISITION [J].
DOWELL, SF ;
TOROK, TJ ;
THORP, JA ;
HEDRICK, J ;
ERDMAN, DD ;
ZAKI, SR ;
HINKLE, CJ ;
BAYER, WL ;
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) :1076-1079
[10]   OCCUPATIONAL RISK OF HUMAN PARVOVIRUS-B19 INFECTION FOR SCHOOL AND DAY-CARE PERSONNEL DURING AN OUTBREAK OF ERYTHEMA-INFECTIOSUM [J].
GILLESPIE, SM ;
CARTTER, ML ;
ASCH, S ;
ROKOS, JB ;
GARY, GW ;
TSOU, CJ ;
HALL, DB ;
ANDERSON, LJ ;
HURWITZ, ES .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15) :2061-2065